SYSTEMIC IMMUNE PROFILING OF ADVANCED BILIARY TRACT CANCER PATIENTS DEFINES ALTERED CYTOKINES AND IMMUNE CELL POPULATIONS

被引：0
|
作者：
Ruggieri, Amanda [1 ]
Yarchoan, Mark [2 ]
Liu, Yuan [1 ]
Goyal, Subir [1 ]
Sharon, Elad [3 ]
Chen, Helen [3 ]
Olson, Brian [1 ]
Maithel, Shishir [1 ]
El-Rayes, Bassel [1 ]
Azad, Nilofer [2 ]
Lesinski, Gregory [1 ]
机构：
[1] Emory Univ, Atlanta, GA 30322 USA
[2] Johns Hopkins Univ, Baltimore, MD USA
[3] NCI, Bethesda, MD 20892 USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2021年 / 9卷
关键词：
D O I：
10.1136/jitc-2021-SITC2021.018
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
18
引用
收藏
页码：A20 / A20
页数：1
相关论文
共 50 条
  • [21] DNA checkpoint gene mutation as a biomarker of immune checkpoint inhibitor in advanced biliary tract cancer
    Shin, Ji Eun
    Kim, Seung Tae
    Choi, Dae-Ho
    Lee, Junho
    Hyeon, Jiyeon
    CANCER RESEARCH, 2024, 84 (06)
  • [22] Tumor Mutational Burden Is a Potential Predictive Biomarker for Response to Immune Checkpoint Inhibitors in Patients With Advanced Biliary Tract Cancer
    Liddell, Savannah S.
    Chakrabarti, Sakti
    Wintheiser, Grant A.
    Zemla, Tyler J.
    Shi, Qian
    Tella, Sri Harsha
    Jin, Zhaohui
    Wookey, Vanessa B.
    Hassan, Hind
    Tran, Nguyen H.
    Borad, Mitesh J.
    Mahipal, Amit
    JCO PRECISION ONCOLOGY, 2022, 6
  • [23] Immune profiling in elderly cancer patients for predicting immune senescence
    Kim, Hye Ryun
    Kim, Soo Jung
    Shin, Sang Joon
    Kwon, Woo Sun
    Kim, Tae Soo
    Ahn, Joong Bae
    Song, Jaewoo
    Oh, Chang
    Rha, Sun Young
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [24] New developments in systemic therapy for advanced biliary tract cancer
    Morizane, Chigusa
    Ueno, Makoto
    Ikeda, Masafumi
    Okusaka, Takuji
    Ishii, Hiroshi
    Furuse, Junji
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2018, 48 (08) : 703 - 711
  • [25] Immune checkpoint inhibitor therapy in biliary tract cancer (cholangiocarcinoma)
    Jakubowski, Christopher D.
    Azad, Nilofer S.
    CHINESE CLINICAL ONCOLOGY, 2020, 9 (01)
  • [26] Genomic alterations predict clinical response to systemic chemotherapy and immune checkpoint blockade in biliary tract cancer
    Kim, M. H.
    Yoon, J.
    Jang, M.
    Kim, H.
    Park, Y. N.
    Lee, M. G.
    Hwang, H. K.
    Kang, C. M.
    Lee, W. J.
    Kang, B.
    Chung, H. C.
    Choi, H. J.
    ANNALS OF ONCOLOGY, 2019, 30
  • [27] Immune profiling of the macroenvironment in colorectal cancer unveils systemic dysfunction and plasticity of immune cells
    Ke, Haoxian
    Li, Peisi
    Li, Zhihao
    Zeng, Xian
    Zhang, Chi
    Luo, Shuzhen
    Chen, Xiaofang
    Zhou, Xinlan
    Dong, Shichen
    Chen, Shaopeng
    Huang, Junfeng
    Yuan, Ming
    Yu, Runfeng
    Ye, Shubiao
    Hu, Tuo
    Tang, Zhonghui
    Liu, Dongbin
    Wu, Kui
    Wu, Xianrui
    Lan, Ping
    CLINICAL AND TRANSLATIONAL MEDICINE, 2025, 15 (02):
  • [28] Expression of PD-L1 as a predictive marker of sensitivity to immune checkpoint inhibitors in patients with advanced biliary tract cancer
    Kim, Hongsik
    Kim, Ryul
    Jo, Hyunji
    Kim, Hye Ryeon
    Hong, Joohyun
    Ha, Sang Yun
    Park, Joon Oh
    Kim, Seung Tae
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2022, 15
  • [29] DNA Checkpoint Gene Mutation as a Biomarker for Immune Checkpoint Inhibitor Therapy in Advanced Biliary Tract Cancer
    Shin, Ji Eun
    Kim, Seung Tae
    ANTICANCER RESEARCH, 2024, 44 (05) : 2103 - 2108
  • [30] Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures
    Mody, Kabir
    Jain, Prerna
    El-Refai, Sherif M.
    Azad, Nilofer S.
    Zabransky, Daniel J.
    Baretti, Marina
    Shroff, Rachna T.
    Kelley, R. Katie
    El-Khouiery, Anthony B.
    Hockenberry, Adam J.
    Lau, Denise
    Lesinski, Gregory B.
    Yarchoan, Mark
    JCO PRECISION ONCOLOGY, 2022, 6
12345